ArticleOncotarget2016

Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.

Ling Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.